Literature DB >> 1622543

T-cell-targeted immunotherapy.

M Feldmann1, C H June, A McMichael, R Maini, E Simpson, J N Woody.   

Abstract

The pace of T-cell research is matched only by the speed with which fundamental advances are being developed as new therapies. This report from a recent meeting updates developments in a number of immunointervention strategies.

Mesh：

Substances：

Year:  1992        PMID： 1622543     DOI： 10.1016/0167-5699(92)90146-X

Source DB:  PubMed          Journal:  Immunol Today        ISSN： 0167-5699


  5 in total

1.  Antigenic mimicry of natural L-peptides with retro-inverso-peptidomimetics.

Authors:  G Guichard; N Benkirane; G Zeder-Lutz; M H van Regenmortel; J P Briand; S Muller
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

Review 2.  Immunological studies on type 1 diabetes in identical twins.

Authors:  M Peakman; R D Leslie; D Vergani
Journal:  Arch Dis Child       Date:  1993-07       Impact factor: 3.791

3.  Lymphocyte vaccination prevents spontaneous diabetes in the non-obese diabetic mouse.

Authors:  R A Smerdon; M Peakman; M J Hussain; D Vergani
Journal:  Immunology       Date:  1993-11       Impact factor: 7.397

4.  Residues within the alpha subunit sequence 304-322 of muscle acetylcholine receptor forming autoimmune CD4+ epitopes in BALB/c mice.

Authors:  P I Karachunski; N Ostlie; B M Conti-Tronconi; M Bellone
Journal:  Immunology       Date:  1994-05       Impact factor: 7.397

5.  The cytokines NAP-1 (IL-8), MCP-1, IL-1 beta, and GRO in rabbit inflammatory skin lesions produced by the chemical irritant sulfur mustard.

Authors:  J Tsuruta; K Sugisaki; A M Dannenberg; T Yoshimura; Y Abe; P Mounts
Journal:  Inflammation       Date:  1996-06       Impact factor: 4.092
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.